Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Cardiac AL Amyloidosis
NCT03474458Phase 3Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Feb 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of doxycycline in Cardiac AL amyloidosis (AL-CA), sponsored by IRCCS San Matteo Foundation. Started Feb 2019; status: terminated.
02
Drugs
doxycycline
03
Conditions
Cardiac AL amyloidosis (AL-CA)
Beyond the preview
Go deeper on NCT03474458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03474458.